A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma

GÜNDOĞ M., BAŞARAN H., BOZKURT O., EROĞLU C.

BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, cilt.86, sa.6, ss.676-686, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 86 Sayı: 6
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.bjorl.2019.04.008
  • Dergi Adı: BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.676-686
  • Anahtar Kelimeler: Cumulative cisplatin dose, Chemotherapy schedule, Nasopharyngeal carcinoma, MODULATED RADIATION-THERAPY, LOCALLY ADVANCED HEAD, PHASE-III, 3-WEEKLY CISPLATIN, ADJUVANT CHEMOTHERAPY, RANDOMIZED-TRIAL, STAGE-III, RADIOTHERAPY, CANCER, NECK
  • Erciyes Üniversitesi Adresli: Evet

Özet

Introduction: Three-weekly cisplatin dose is accepted for standard treatment for concurrent chemo-radiotherapy in nasopharyngeal carcinoma. However, different chemotherapy schedules are presented in the literature.